A Combined Phase I and II, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety for Prevention and Treatment of Radiation Therapy Burn of CH1701
Latest Information Update: 05 May 2022
At a glance
- Drugs CH 1701 (Primary)
- Indications Radiation-induced skin damage
- Focus Adverse reactions; Therapeutic Use
- Sponsors Vietlife Healthcare Corporation
- 21 Aug 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.
- 21 Aug 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Dec 2020.
- 19 May 2020 New trial record